Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab

Purpose The purpose of this case report is to outline the management of a 41-year-old female with pathological myopia and type II choroidal neovascularization (CNV) diagnosed by optical coherence tomography angiography (OCT-A) angio-B mode. Observations The early detection of CNV with OCT-A angio-B...

Descripción completa

Detalles Bibliográficos
Autores: Rico, Stephanie, Sher, Ifat, Lavinsky, Fábio, Lavinsky, Daniel, Rotenstreich, Ygal
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:Brasil
Institución:Universidade Federal do Rio Grande do Sul (UFRGS)
Repositorio:Repositório Institucional da UFRGS
Idioma:inglés
OAI Identifier:oai:www.lume.ufrgs.br:10183/289107
Acceso en línea:http://hdl.handle.net/10183/289107
Access Level:acceso abierto
Palabra clave:Miopia
Bevacizumab
Tomografia de coerência óptica
Choroidal neovascularization
Myopia
Optical coherence tomography angiography
Angio-B mode
id BR_95eb031b1335d3adc1dd39b61c19d8cc
oai_identifier_str oai:www.lume.ufrgs.br:10183/289107
network_acronym_str BR
network_name_str Brasil
repository_id_str
spelling 2025-03-27T06:41:55Z20242451-9936http://hdl.handle.net/10183/289107001243883Purpose The purpose of this case report is to outline the management of a 41-year-old female with pathological myopia and type II choroidal neovascularization (CNV) diagnosed by optical coherence tomography angiography (OCT-A) angio-B mode. Observations The early detection of CNV with OCT-A angio-B mode and treatment with intra-vitreous injections of Bevacizumab contributed to the amelioration of her vision to 20/20, a better visual acuity than she had prior to treatment. Conclusions and importance This case report suggests that an OCT-A scan may reveal the initial formation of abnormal vasculature before pathological changes are evident in structural OCT, allowing for prompt treatment and resolution in patients with myopic CNV.application/pdfengAmerican journal of ophthalmology case reports. [Atlanta]. Vol. 34 (June 2024), 102041, 5 p.MiopiaBevacizumabTomografia de coerência ópticaChoroidal neovascularizationMyopiaOptical coherence tomography angiographyBevacizumabAngio-B modeOptical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with BevacizumabEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSRico, StephanieSher, IfatLavinsky, FábioLavinsky, DanielRotenstreich, YgalTEXT001243883.pdf.txt001243883.pdf.txtExtracted Texttext/plain18223http://www.lume.ufrgs.br/bitstream/10183/289107/2/001243883.pdf.txt5d526cecc7e870c5323cd47b5780c7fdMD52ORIGINAL001243883.pdfTexto completo (inglês)application/pdf5010679http://www.lume.ufrgs.br/bitstream/10183/289107/1/001243883.pdf3906ae15724a7100361fcd34ffdab527MD5110183/2891072025-03-28 06:43:48.022408oai:www.lume.ufrgs.br:10183/289107Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2025-03-28T09:43:48Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
title Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
spellingShingle Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
Rico, Stephanie
Miopia
Bevacizumab
Tomografia de coerência óptica
Choroidal neovascularization
Myopia
Optical coherence tomography angiography
Bevacizumab
Angio-B mode
title_short Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
title_full Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
title_fullStr Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
title_full_unstemmed Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
title_sort Optical coherence tomography Angio-B mode for early detection of myopic choroidal neovascularization and treatment with Bevacizumab
dc.creator.none.fl_str_mv Rico, Stephanie
Sher, Ifat
Lavinsky, Fábio
Lavinsky, Daniel
Rotenstreich, Ygal
author Rico, Stephanie
author_facet Rico, Stephanie
Sher, Ifat
Lavinsky, Fábio
Lavinsky, Daniel
Rotenstreich, Ygal
author_role author
author2 Sher, Ifat
Lavinsky, Fábio
Lavinsky, Daniel
Rotenstreich, Ygal
author2_role author
author
author
author
dc.subject.por.fl_str_mv Miopia
Bevacizumab
Tomografia de coerência óptica
topic Miopia
Bevacizumab
Tomografia de coerência óptica
Choroidal neovascularization
Myopia
Optical coherence tomography angiography
Bevacizumab
Angio-B mode
dc.subject.eng.fl_str_mv Choroidal neovascularization
Myopia
Optical coherence tomography angiography
Bevacizumab
Angio-B mode
description Purpose The purpose of this case report is to outline the management of a 41-year-old female with pathological myopia and type II choroidal neovascularization (CNV) diagnosed by optical coherence tomography angiography (OCT-A) angio-B mode. Observations The early detection of CNV with OCT-A angio-B mode and treatment with intra-vitreous injections of Bevacizumab contributed to the amelioration of her vision to 20/20, a better visual acuity than she had prior to treatment. Conclusions and importance This case report suggests that an OCT-A scan may reveal the initial formation of abnormal vasculature before pathological changes are evident in structural OCT, allowing for prompt treatment and resolution in patients with myopic CNV.
publishDate 2024
dc.date.issued.fl_str_mv 2024
dc.date.accessioned.fl_str_mv 2025-03-27T06:41:55Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/289107
dc.identifier.issn.pt_BR.fl_str_mv 2451-9936
dc.identifier.nrb.pt_BR.fl_str_mv 001243883
identifier_str_mv 2451-9936
001243883
url http://hdl.handle.net/10183/289107
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv American journal of ophthalmology case reports. [Atlanta]. Vol. 34 (June 2024), 102041, 5 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/289107/2/001243883.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/289107/1/001243883.pdf
bitstream.checksum.fl_str_mv 5d526cecc7e870c5323cd47b5780c7fd
3906ae15724a7100361fcd34ffdab527
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv lume@ufrgs.br
_version_ 1853662849943994368
score 15,300719

Similares en LA Referencia